CANCER OF THE FEMALE REPRODUCTIVE SYSTEM IN THE FAR EASTERN FEDERAL DISTRICT

The aim of the study was to assess the incidence and mortality rates of female reproductive system cancer in the Far Eastern Federal District over the last ten years (2008–2017).

Material and Methods. In our study we used statistical reports on the female reproductive system cancer incidence and mortality rates and 10-year follow-up data.

Results. In 2017, 25155 new cases of female reproductive system cancer were diagnosed in the Far Eastern Federal District (26.6 % higher than in 2008). A total of 128776 patients (2.1 % of the population of the region) were followed up. Over the study period, there has been increase in the number of patients with stage I–II breast cancer (+4.8 %), cervical cancer (+6.3 %), uterine body (+3.9 %) and ovarian cancer (+5.7 %), with simultaneous reduction in the number of patients with advanced stages, except ovarian cancer (+5.0 %). For the past 10 years, cancer incidence rates have been steadily increasing, while cancer mortality rates have been decreasing with the exception of cervical cancer (+13.7 %). Morphological confirmation of the diagnosis (over 90 %) exceeded the national average ones. The number of patients followed-up for 5 or more years appeared to be lower than the average values in Russia; however the 1-year mortality rates after diagnosis improved. Ovarian cancer remains the most deadly of the gynecological cancers (22.9–27.9 %).

Conclusion. Over the last ten years in the Far Eastern Federal District, in contrast to the overall decline in the mortality rates, there has been a steady increase in the incidence rates of female reproductive system cancer, except for cervical cancer. 

1. Agadzhanyan N.A., Uyba V.V., Kulikova M.P., Kochetkova A.V. Actual problems of adaptation, environmental and rehabilitation medicine. Moscow, 2006. 208 p. (in Russian).

2. Balashov P.Yu., Starinsky VV, Alexandrova L.M. Human resources of the oncological service of Russia. European Oncology Journal. 2014; 3 (03): 976. (in Russian).

3. Gordienko V.P., Vakhnenko A.A. Probable factors of social risk of oncological pathology in a separately taken region. Siberian Medical Journal (Irkutsk). 2012; 115(8): 86–89. (in Russian).

4. Gordienko V.P., Vakhnenko A.A., Sapegina O.V., Rolko E.M. Major avenues of work for improving medical care for cancer patients in the context of modern social and economic conditions in a particular region. Electronic Scientific Journal «Social aspects of population health». 2014; (3) [Internet]. URL: http://vestnik.mednet.ru/content/view/568/30/lang.ru/ (cited 17.01.2017). (in Russian).

5. Chissov V.I., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2008 (morbidity and mortality). Moscow, 2009. (in Russian).

6. Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow, 2018. 255 p. (in Russian).

7. International Statistical Classification of Diseases and Health Problems. X revision. WHO. Geneva. 1995. 1: 698. (in Russian).

8. Merabishvili V.M. Oncological statistics (traditional methods, new information technologies). Saint-Petersburg, 2011. Part 1. 224 p. (in Russian).

9. Davydov M.I., Petrovsky A.V. Oncology. Clinical recommendations. Moscow, 2018. 976 p. (in Russian).

10. Pletnev V.V. Identification of cancer susceptibility and methods of its primary prevention. Moscow, 2015. 160 р. (in Russian).

11. Russia in numbers. 2019: A Brief Statistical Digest. Moscow, 2019. 549 p. (in Russian).

12. Chissov V.I., Starinsky V.V., Petrova G.V. The state of cancer care in Russia in 2008. Moscow, 2009. 191 p. (in Russian).

13. Kaprin A.D., Starinsky V.V., Petrova G.V. The status of cancer care for the population of Russia in 2017. Moscow, 2018. 236 p. (in Russian).

14. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global Cancer Statistics: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018 Nov; 68(6): 394–424. doi: 10.3322/caac.21492.

15. Swerdlow A.J., Harvey C.E., Milne R.L., Pottinger C.A., Vachon C.M., Rwilkens L., Winn D. The national cancer institute cohort consortium: An international pooling collaboration of 58 cohorts from 20 countries. Cancer Epidemiol Biomarkers Prev. 2018 Nov; 27(11): 1307–1319. doi: 10.1158/1055-9965.EPI-18-0182.